This is an automatically translated article.
The drug Inolanfra has the main ingredient is Lansoprazole, which is often used in the treatment of gastroesophageal reflux disease - esophagitis, gastric and duodenal ulcers,... Let's learn about the uses of Inolanfra in the article below.1. What is Inolanfra?
Inolanfra is manufactured by Daewoong Pharm Co., Ltd - Korea and circulated on the market with registration number VN-13114-11. Inolanfra is a prescription drug that belongs to the group of gastrointestinal drugs. The main active ingredient of inolanfra is Lansoprazole.
Dosage form: Enteric film-coated tablets, each containing 30mg of Lansoprazole and other excipients of the manufacturer.
Packing form: Blister of 10 tablets, box of 3 blisters and instruction sheet for drug use.
2. What disease does Inolanfra treat?
Lansoprazole is a potent inhibitor of acid secretion by inhibiting the enzyme H+,K+ ATPase activity in parietal cells of the gastric mucosa. In clinical practice, Lansoprazole achieves a fast and high healing rate for gastric ulcer and duodenal ulcer. In addition, Lansoprazole has also been shown to be effective in the treatment of reflux esophagitis as well as Zollinger-Ellison syndrome.Contraindications of Inolanfra: Do not use Inolanfra for patients with hypersensitivity to any of the ingredients.
3. Dosage and how to use Inolanfra
Inolanfra is a prescription drug, so patients should only use this medicine when prescribed by a doctor. At the same time, patients need to adhere to the treatment regimen including dosage, route of administration and duration of medication. Do not share Inolanfra with other people or give it to others to use even if they have the same diagnosis as you.
Dosage:
Usual adult dose for duodenal ulcer: 30mg/day, used for 4 weeks. Usual adult dose for peptic ulcer - oesophagitis: 30mg/day, used for 8 weeks. Usual Adult Dose for Gastroesophageal Reflux: 30mg/day, used for 4-8 weeks. Usual Adult Dose for Zollinger - Ellison Syndrome: Dosage is adjusted according to individual patient symptoms. Usage: Inolanfra is prepared as enteric film-coated tablets and administered orally. The drug is taken in the morning before eating, swallow the tablet whole with a sufficient amount of water, do not chew or break the tablet.
What to do if you miss a dose of Inolanfra?
In case of missed dose: You can take another dose as soon as you remember, if it is almost time for the next dose, you can skip the missed dose. Do not add a dose to make up for a missed dose.
What to do in case of an overdose of Inolanfra?
When an overdose is suspected, it is necessary to quickly bring the patient to the nearest hospital for treatment. Family members need to bring medical examination number and medications the patient is taking to support the diagnosis.
4. Undesirable effects
In addition to the therapeutic effect, Inolanfra may cause some unwanted effects during use such as:
Manifestations of hypersensitivity reactions: Rash, itching. If this occurs, you should stop taking the drug. In addition, when any of the following signs are detected, take the patient to the nearest hospital immediately: Urticaria, swelling of the eyes, lips, mouth, tongue, throat, blistering, peeling skin, difficulty breathing, hoarseness voice, difficulty swallowing, fast heartbeat, extreme fatigue, muscle spasms, convulsions, severe diarrhea, abdominal pain, fever. On the liver: increased liver enzymes, alkaline phosphatase, LDH, G-GTP. Blood and hematopoietic system: anemia, leukopenia, eosinophilia, thrombocytopenia. Digestive system: constipation, diarrhea, abdominal distension, dry mouth. Nervous system and nervous system: headache, somnolence, insomnia, dizziness. Other undesirable effects: fever, increase in total cholesterol, increase in uric acid,... The above is not a complete list of unwanted effects of Inolanfra, patients may experience symptoms. other not listed, reported. Therefore, it is necessary to contact your doctor immediately if you have any unusual symptoms or signs while using Inolanfra.
5. Drug interactions
Treatment with many drugs can cause interactions between the ingredients in the drug, leading to changes in drug activity. In addition, some medical conditions such as cancer, immunodeficiency, diabetes, ... foods and beverages can also affect the absorption, effects, and side effects of the drug. medicine. Therefore, to ensure safety, the patient needs to tell the doctor about all the medicines he is using, the diseases he is having. At the same time, consult your doctor about some foods and drinks that may need to be limited during drug use such as alcohol, stimulants, ... Some drugs can interact with Inolanfra such as:
Inolanfra's ability to interact with other drugs (Prilosec, Zegerid) is quite similar to that of Omeprazole.
The absorption of some drugs can be affected by stomach acid, Inolanfra reduces stomach acid, thereby also reducing the absorption and blood concentration of ketoconazole (resulting in a decrease in the effectiveness of ketoconazole). ), which increases the absorption and blood concentration of digoxin (resulting in digoxin toxicity).
Inolanfra increases blood levels of methotrexate, tacrolimus.
Inolanfra may also increase the effects of warfarin and increase the risk of bleeding.
6. Some notes when using Inolanfra
Use of Inolanfra during pregnancy and lactation: In rats, fetal serum concentrations of Inolanfra were higher than in maternal rats. In rabbits, oral doses of 30 mg Inolanfra increased embryonic mortality. Therefore, this drug should not be used in pregnant women unless absolutely necessary. There have been reports in laboratory animals that Inolanfra is excreted in human milk, so this drug should not be administered to a nursing mother. Use of Inolanfra in children: There is insufficient evidence for the safety of this medicine in children. Using Inolanfra for the elderly: In the elderly, gastric acid secretion and physiological functions of the liver and kidneys decline, so Inolanfra should be used with caution. Before taking Inolanfra, tell your doctor: All medications, supplements, herbs, vitamins, minerals you are taking. Current medical condition and history if ever seizures, heart disease, hyperthyroidism, hypothyroidism, tumors, high blood pressure, liver disease, alcohol abuse. During treatment with Inolanfra, it is necessary to closely monitor the patient's condition, do not use Inolanfra for maintenance treatment if there is not enough experience in long-term use of the drug.
7. Preservation of drugs
It is necessary to store Inolanfra in the original packaging of the manufacturer, in a cool, clean place to avoid direct sunlight. Keep Inolanfra out of reach of children as well as pets, avoid them not knowing how to chew can cause serious unwanted effects. Do not use Inolanfra medicine that has expired or shows signs of change in color, properties, taste, no labels. Do not throw Inolanfra down the toilet or plumbing unless told to do so.
